Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK544685Aexternal-prioritypatent/DK544685D0/da
Priority claimed from DK459286Aexternal-prioritypatent/DK459286D0/da
Application filed by Novo Industri AsfiledCriticalNovo Industri As
Priority to DK563886ApriorityCriticalpatent/DK156699C/da
Publication of DK563886D0publicationCriticalpatent/DK563886D0/da
Publication of DK563886ApublicationCriticalpatent/DK563886A/da
Publication of DK156699BpublicationCriticalpatent/DK156699B/da
Application grantedgrantedCritical
Publication of DK156699CpublicationCriticalpatent/DK156699C/da
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
DK563886A1985-11-261986-11-25Anvendelse af faktor viia til fremstilling af en terapeutisk komposition til behandling af bloedningsforstyrrelser
DK156699C
(da)
Pharmazeutische zusammensetzung, enthaltend 2',3'-dideoxycytidin-2'-en(2',3'-dideoxy-2',3'didehydrocytidin) zur behandlung von mit retrovirus infizierten patienten.
Zusammensetzungen enthaltend Lipoprotein-Associated-Coagulation-Inhibitor (LACI) zur Herstellung eines Medikaments zur Behandlung von akuten oder chronischen Enzündungen